Golfho, have you given much thought about how "forward guidance" of the negatives were given by Avid BOD
They were so gracious ...actually as if hoping more would sell out ...due to the 2 or 3 week mandatory shutdown of some equipment
Now here we are just days away from when they tell us how we would have done better so I assume they remind everyone of more details of those shutdowns and give the positive guidance forward
Seems strange that the BODs have initiated other CDMOs with deal talks (the same Patrick Walsh and Mark Bamforth ties ) and even some deals with ThermoFisher ...yet here, it is as if some higher powers trying to squeeze out some more shares
____
I remember the talks at the ASM reminded shareholders of some info below:...
We are looking at collaborations with our clients, which is increasingly being used in biologics. Clients may participate in a low/no-interest loan. They may pay for their own equipment for us to create their product. If they participate in financing, then they have dedicated capacity. Vendors may give help via discounts and other incentives. We are VERY sensitive to dilution and would not do that unless we had an acquisition that would be a game-changer or had a very significant adding of capacity.
Post 332097 332104
____
So no details given yet to us shareholders but Ampersand spending Millions on new ventures and making deals with ThermoFisher ...very strange
Now, a collaboration of PS Targeting...in Omeros....have new Biomarkers "BASED UPON" PS Targeting and they just publicly disclosed Thursday this past week....that the FDA approved ...but they can't disclose the Biomarkers / surrogate endpoints
News 
Market Data 
Discover 
AI
